Article
Activation of estrogen receptor α increases and estrogen receptor β decreases apolipoprotein E expression in hippocampus <i>in vitro</i> and <i>in vivo</i>
2 Nov 2006
Abstract excerpt
Previous evidence indicates that, in carriers of apolipoprotein E4 (ApoE4), estrogen therapy increased the risk of late-onset Alzheimer's disease (AD), whereas in individuals carrying ApoE2/3, estrogen therapy reduced the risk of AD [Cauley JA, Zmuda JM, Yaffe K, Kuller LH, Ferrell RE, Wisniewski SR, Cummings SR (1999) J Bone Miner Res 14:1175-1181; Yaffe K, Haan M, Byers A, Tangen C, Kuller L (2000) Neurology...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
